Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $7.78B | $6.53B | $6.30B | $6.17B | $6.26B | $6.40B | $6.22B |
| Revenue growth | — | -16.0% | -3.5% | -2.1% | 1.4% | 2.2% | -2.9% |
| Gross profit | — | — | — | $3.88B | $3.75B | $3.71B | $3.31B |
| Gross margin | — | — | — | 62.8% | 59.8% | 58.0% | 53.3% |
| Net income | $3.22B | $2.16B | $1.35B | $917M | $1.02B | $864M | $187M |
| Net margin | 41.4% | 33.1% | 21.4% | 14.9% | 16.3% | 13.5% | 3.0% |
| EPS (diluted) | $12.69 | $8.52 | $5.31 | $3.59 | $3.99 | $3.33 | $0.72 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.02B | $2.28B | $2.16B | $858M | $799M | $939M | $700M |
| Capital expenditures | $92.0M | $255M | $192M | $196M | $251M | $175M | $162M |
| Free cash flow | $2.93B | $2.03B | $1.97B | $662M | $548M | $764M | $538M |
| Dividends paid | $0.00 | $0.00 | $145M | $290M | $294M | $297M | $88.0M |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $0.00 | $12.0M | $737M | $706M | $693M | $675M | $574M |
| Total assets | — | $10.1B | $10.7B | $11.0B | $12.1B | $13.1B | $12.9B |
| Total liabilities | — | — | — | $11.8B | $12.1B | $12.6B | $12.1B |
| Long-term debt | — | $0.00 | $9.13B | $8.90B | $8.75B | $8.86B | $8.63B |
| Shareholders' equity | $7.04B | $5.49B | -$1.51B | -$892M | -$70.0M | $472M | $752M |
| Retained earnings | — | $0.00 | -$998M | -$331M | $443M | $1.01B | $1.11B |
| Shares (wtd avg diluted) | 254M | 254M | 254M | 255M | 256M | 259M | 261M |
Every figure is extracted from Organon & Co.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.